Because gut-liver axis regulation and gut microbiota dysbiosis have been highlighted as crucial pathogenic factors in MASLD (26–28), we assessed the diversity of the gut bacterial community and differences in bacterial species abundance between ApoH−/− and WT mice. The gene discussed is APOH; the disease is metabolic dysfunction-associated steatotic liver disease.